References
- Turunen, S., M. K. Koivula, J. Melkko, et al. 2013. Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritis. J. Transl. Med. 11: 224
- Turunen, S., P. Hannonen, M. K. Koivula, et al. 2015. Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptides. Arthritis Res. Ther. 17: 2
- Turunen, S., M. K. Koivula, L. Risteli, and J. Risteli. 2010. Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits. Arthritis Rheum. 62: 3345–3352
- Nielen, M. M., D. van Schaardenburg, H. W. Reesink, et al. 2004. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 50: 380–386
- Koivula, M. K., M. Heliovaara, J. Ramberg, P. Knekt, et al. 2007. Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis. Ann. Rheum. Dis. 66: 1450–1455
- Koivula, M. K., S. Aman, E. Alasaarela, et al. 2006. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis. Rheumatology 45: 1364–1369
- Vencovsky, J., S. Machacek, L. Sedova, J. Kafkova, et al. 2003. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann. Rheum. Dis. 62: 427–430
- Shi, J., A. Willemze, G. M. Janssen, P. A. van Veelen, et al. 2013. Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the ‘AMC-senshu’ method. Ann. Rheum. Dis. 72: 148–150
- Kraus, L. M., and A. P. Kraus, Jr. 2001. Carbamoylation of amino acids and proteins in uremia. Kidney Int. 78: S102–S107
- Wang, Z., S. J. Nicholls, E. R. Rodriguez, et al. 2007. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat. Med. 13: 1176–1184
- Shi, J., R. Knevel, P. Suwannalai, et al. 2011. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc. Natl. Acad. Sci. USA 108: 17372–17377
- Gyorgy, B., E. Toth, E. Tarcsa, et al. 2006. Citrullination: a posttranslational modification in health and disease. Int. J. Biochem. Cell Biol. 38: 1662–1677
- Gudmann, N. S., N. U. Hansen, A. C. Jensen, et al. 2015. Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options. Autoimmunity 48: 73–79
- Khandpur, R., C. Carmona-Rivera, A. Vivekanandan-Giri, et al. 2013. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci. Transl. Med. 5: 178ra40
- Mydel, P., Z. Wang, M. Brisslert, et al. 2010. Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J. Immunol. 184: 6882–6890
- van der Woude, D., S. Rantapaa-Dahlqvist, A. Ioan-Facsinay, et al. 2010. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann. Rheum. Dis. 69: 1554–1561
- van de Stadt, L. A., M. H. de Koning, R. J. van de Stadt, et al. 2011. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. Arthritis Rheum. 63: 3226–3233
- Sokolove, J., R. Bromberg, K. D. Deane, et al. 2012. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 7: e35296
- Lundberg, K., S. Nijenhuis, E. R. Vossenaar, et al. 2005. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res. Ther. 7: R458–R467